Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics, domperidone, or both versus placebo for prevention of ventilator-associated pneumonia in severe traumatic brain injury
IRCT20190810044500N28Phase 2Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of domperidone in ventilator-associated pneumonia (VAP) (4 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: Mortality rate, Duration of ventilation and 4 more. Started Oct 2024; status: completed.
02
Drugs
domperidone
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on IRCT20190810044500N28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190810044500N28.